{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:41Z","timestamp":1790916821625,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cardiac troponins are essential structural proteins found in the contractile apparatus of cardiac myocytes. During myocardial damage, such as in myocardial infarction (MI), these troponins are released into the bloodstream. As a result, they play a central role in the diagnosis of MI, serving as sensitive and specific markers for cardiac injury. Earlier assays that were used for measuring troponin levels were considered as a dichotomous test, categorizing patients as being positive or negative for MI. The recent introduction of high-sensitivity cardiac troponin assays has revolutionized cardiac troponin detection. These assays can detect troponin levels that are 100 times lower than what traditional methods can detect. Hence it is now considered a quantitative measure of cardiac myocyte injury not only in the setting of MI but also in subjects without MI such as heart failure, in whom it can be regarded as a marker for myocardial stress. This review aims to establish the relationship between high-sensitivity cardiac troponin levels and the prognosis of patients suffering from acute heart failure. Additionally, this seeks to identify other applications where the release of troponin from the cardiomyocyte can provide prognostic information. This information can be vital in determining the appropriate treatment options for patients, ultimately improving their quality of life and positively impacting health economics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000732","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T09:06:15Z","timestamp":1732698375000},"page":"488-495","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["High-Sensitivity Cardiac Troponin Assays in Acute Heart Failure, Moving Beyond Myocardial Infarction"],"prefix":"10.1097","volume":"34","author":[{"given":"Abhishek","family":"Kumar","sequence":"first","affiliation":[{"name":"From the Department of Cardiology, All India Institute of Medical Sciences Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Neurology, DKS Postgraduate Institute and Research Centre, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneshwar","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amratansh","family":"Varshney","sequence":"additional","affiliation":[{"name":"Department of Cardiology, All India Institute of Medical Sciences Raipur, Chhattisgarh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1373\/clinchem.2016.255109","article-title":"IFCC task force on clinical applications of cardiac bio-markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care.","volume":"63","author":"Apple","year":"2017","journal-title":"Clin Chem"},{"key":"R2-20261002","first-page":"e618","article-title":"Fourth universal definition of myocardial infarction (2018) [published correction appears in circulation. 2018 Nov 13;138(20):e652].","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2018.09.082","article-title":"Cardiac troponin elevation in patients without a specific diagnosis.","volume":"73","author":"Eggers","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/heartindia.heartindia_7_24","article-title":"Prevalence and prognostic significance of iron deficiency anemia among heart failure patients: a prospective observational study.","volume":"12","author":"Naeem","year":"2024","journal-title":"Heart India"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0002-9149(91)90466-X","article-title":"Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.","volume":"67","author":"Katus","year":"1991","journal-title":"Am J Cardiol"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2019.06.005","article-title":"Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.","volume":"293","author":"Aimo","year":"2019","journal-title":"Int J Cardiol"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.CIR.103.16.2035","article-title":"Preload induces troponin I degradation independently of myocardial ischemia.","volume":"103","author":"Feng","year":"2001","journal-title":"Circulation"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/VHRM.S327661","article-title":"The main causes and mechanisms of increase in cardiac troponin concentrations other than acute myocardial infarction (Part 1): physical exertion, inflammatory heart disease, pulmonary embolism, renal failure, sepsis [published correction appears in Vasc Health Risk Manag. 2021 Oct 11;17:659-660].","volume":"17","author":"Chauin","year":"2021","journal-title":"Vasc Health Risk Manag"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"9713326","DOI":"10.1155\/2022\/9713326","article-title":"High-sensitivity troponin: a review on characteristics, assessment, and clinical implications.","volume":"2022","author":"Lazar","year":"2022","journal-title":"Dis Markers"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2018.10.065","article-title":"Single-molecule hsTnI and short-term risk in stable patients with chest pain [published correction appears in J Am Coll Cardiol. 2021 Mar 9;77(9):1269-1274].","volume":"73","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R11-20261002","first-page":"450","article-title":"The study group on biomarkers of the ESC association for acute cardiovascular care.","volume":"11","author":"Mueller","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2013.12.032","article-title":"Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.","volume":"63","author":"Gore","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1373\/clinchem.2018.292086","article-title":"Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort.","volume":"64","author":"Welsh","year":"2018","journal-title":"Clin Chem"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaccas.2020.01.012","article-title":"Cardiac troponin and the true false positive.","volume":"2","author":"Januzzi","year":"2020","journal-title":"JACC Case Rep"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jamacardio.2016.0765","article-title":"Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death.","volume":"1","author":"McEvoy","year":"2016","journal-title":"JAMA Cardiol"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/CIRCULATIONAHA.119.043337","article-title":"Incorporation of biomarkers into risk assessment for allocation of antihypertensive medication according to the 2017 ACC\/AHA high blood pressure guideline: a pooled cohort analysis.","volume":"140","author":"Pandey","year":"2019","journal-title":"Circulation"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jacc.2020.05.057","article-title":"Atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium.","volume":"76","author":"Sandoval","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3343\/alm.2023.43.3.225","article-title":"Biomarkers in heart failure: from research to clinical practice.","volume":"43","author":"Berezin","year":"2023","journal-title":"Ann Lab Med"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1373\/clinchem.2009.141341","article-title":"Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.","volume":"56","author":"Alehagen","year":"2010","journal-title":"Clin Chem"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cca.2011.05.007","article-title":"High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension.","volume":"412","author":"Eggers","year":"2011","journal-title":"Clin Chim Acta"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.111.044149","article-title":"Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.","volume":"125","author":"Masson","year":"2012","journal-title":"Circulation"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1253\/circj.CJ-13-1372","article-title":"High-sensitivity cardiac troponin T predicts non-cardiac mortality in heart failure.","volume":"78","author":"Nakamura","year":"2014","journal-title":"Circ J"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ejhf.341","article-title":"Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.","volume":"17","author":"Felker","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5603\/CJ.a2015.0058","article-title":"High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure.","volume":"23","author":"Diez","year":"2016","journal-title":"Cardiol J"},{"key":"R27-20261002","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.117.031560","article-title":"Prognostic value of high-sensitivity troponin t in chronic heart failure: an individual patient data meta-analysis.","volume":"137","author":"Aimo","year":"2018","journal-title":"Circulation"},{"key":"R28-20261002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamacardio.2020.7585","article-title":"Time to clinical benefit of dapagliflozin and significance of prior heart failure hospitalization in patients with heart failure with reduced ejection fraction.","volume":"6","author":"Berg","year":"2021","journal-title":"JAMA Cardiol"},{"key":"R29-20261002","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ihj.2024.04.003","article-title":"Relationship between high sensitivity troponin I and clinical outcomes in non-acute coronary syndrome (non-ACS) acute heart failure patients - a one-year follow-up study.","volume":"76","author":"Kumar","year":"2024","journal-title":"Indian Heart J"},{"key":"R30-20261002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/eurjhf\/hfq210","article-title":"Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.","volume":"13","author":"Xue","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"R31-20261002","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.456","article-title":"Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy.","volume":"18","author":"Perez","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R32-20261002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","article-title":"Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure.","volume":"8","author":"Motiwala","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"R33-20261002","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.","volume":"17","author":"Sanders-van Wijk","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"R34-20261002","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ahj.2012.03.015","article-title":"Highly sensitive troponin T for risk stratification of acutely destabilized heart failure.","volume":"163","author":"Pascual-Figal","year":"2012","journal-title":"Am Heart J"},{"key":"R35-20261002","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/eurheartj\/ehq234","article-title":"Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism.","volume":"31","author":"Lankeit","year":"2010","journal-title":"Eur Heart J"},{"key":"R36-20261002","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0272-6386(03)00746-7","article-title":"Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.","volume":"42","author":"Iliou","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R37-20261002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.117.030320","article-title":"High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome.","volume":"137","author":"Miller-Hodges","year":"2018","journal-title":"Circulation"},{"key":"R38-20261002","doi-asserted-by":"crossref","first-page":"e008032","DOI":"10.1161\/JAHA.117.008032","article-title":"Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease.","volume":"7","author":"Kraus","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R39-20261002","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.113.4.1055","article-title":"Serum cardiac troponin T as a prognostic marker in early sepsis.","volume":"113","author":"Spies","year":"1998","journal-title":"Chest"},{"key":"R40-20261002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jacc.2012.05.028","article-title":"Challenging interpretation of elevated cardiac troponin T in a complex case with rhabdomyolysis.","volume":"60","author":"Giannitsis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R41-20261002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1152\/japplphysiol.00247.2012","article-title":"The kinetics of highly sensitive cardiac troponin T release after prolonged treadmill exercise in adolescent and adult athletes.","volume":"113","author":"Tian","year":"2012","journal-title":"J Appl Physiol (1985)"},{"key":"R42-20261002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000353875","article-title":"What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?.","volume":"36","author":"Anders","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"R43-20261002","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/01.wnl.0000210523.22944.9b","article-title":"Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage.","volume":"66","author":"Hays","year":"2006","journal-title":"Neurology"},{"key":"R44-20261002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000365839","article-title":"The significance of troponin elevation for the clinical course and outcome of first-ever ischaemic stroke.","volume":"38","author":"Lasek-Bal","year":"2014","journal-title":"Cerebrovasc Dis"},{"key":"R45-20261002","doi-asserted-by":"crossref","first-page":"e012797","DOI":"10.1161\/JAHA.119.012797","article-title":"Clinical and biomarker predictors of expanded heart failure outcomes in patients with Type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE trial.","volume":"9","author":"Sharma","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"R46-20261002","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamacardio.2020.2981","article-title":"Clinical application of high-sensitivity troponin testing in the atherosclerotic cardiovascular disease framework of the current cholesterol guidelines.","volume":"5","author":"Marston","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R47-20261002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12055-023-01594-5","article-title":"Prognostic value of high-sensitive troponin T in patients with severe aortic stenosis undergoing valve replacement surgery.","volume":"40","author":"Salama","year":"2024","journal-title":"Indian J Thorac Cardiovasc Surg"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:39Z","timestamp":1790913639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000732","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}